Atmosphere1 / Shutterstock.com
6 February 2025NewsAmericasMarisa Woutersen

Fed Circ raises ‘gamesmanship’ fears in rare patent term dispute

Oral hearings heard the USPTO side with MSD (Merck) over a term extension for a reissued patent, in a case set to have huge implications for pharma market exclusivity, reports Marisa Woutersen.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotechnology
16 May 2024   Puritan Medical argued it had immunity under PREP Act in patent suit | Fed Circ said the district court had not conclusively determined any issue.
Big Pharma
8 August 2023   US Court of Appeals highlights procedural rules in patent dispute concerning medical device charging patents | Medtronic now faces further patent validity reviews after Fed Circ rules in favour of rival.